Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Emicizumab

- PMLiVE

Roche’s Perjeta backed in EU for breast cancer

CHMP recommends use alongside Herceptin

- PMLiVE

Roche invests €200m in Munich biotech centre

Creates new jobs with expansion of German diagnostic production

- PMLiVE

Novo launches haemophilia tracking app

Will compete with similar apps from Pfizer, Baxter

- PMLiVE

Roche wins company of the year at PMEA 2012

Also picks up team of the year at awards to recognise excellence in the pharmaceutical market

Roche - Basel

Roche offers compromise in Tamiflu data debate

Comes as EMA holds workshop on clinical trial data and transparency

- PMLiVE

Astellas seeks FDA approval for personalised Tarceva in lung cancer

Application supported by Roche's EGFR companion diagnostic test

- PMLiVE

Shire promotes Dr Jeff Jonas to lead regenerative medicines business

His former role leading specialty pharma R&D will be filled by Arnaud Partiot

- PMLiVE

Roche’s Avastin cuts progression of aggressive brain cancer

Supports potential new indication for oncology medicine

Roche, social media and patients – part 2

Patient groups talk about their use of social media and the challenges they face

- PMLiVE

EFPIA says “indiscriminate” data transparency could be harmful

Comments come as European Parliament prepares to discuss clinical trial overhaul

Roche, social media and patients – part 1

UK pharma company talks about its digital patient group summit Share+

- PMLiVE

Researcher calls for Roche boycott over missing Tamiflu data

Nordic Cochrane Centre's Peter Gøtzsche also wants European governments to sue the pharma company for withholding data

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links